Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D09SZY
|
||||
Former ID |
DIB016563
|
||||
Drug Name |
IQ-DAA
|
||||
Synonyms |
Anti-anthrax toxin mAb, IQ; Human monoclonal antibodies (anthrax), IQ; IQN-protective antigen (human mAb), IQ corporation; MAb-based immunotherapy (anthrax), IQ; IQNLF + IQNPA (human mAbs, Bacillus anthracis infection), IQ Therapeutics
|
||||
Indication | Bacillus anthracis infection [ICD10:A22] | Phase 1 | [547984] | ||
Company |
IQ Therapeutics BV
|
||||
Target and Pathway | |||||
Target(s) | Protective antigen | Target Info | Modulator | ||
Lethal factor | Target Info | Modulator | |||
Pathway Interaction Database | Cellular roles of Anthrax toxinanthraxpathway:Cellular roles of Anthrax toxin | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.